Hostname: page-component-89b8bd64d-shngb Total loading time: 0 Render date: 2026-05-11T13:19:48.737Z Has data issue: false hasContentIssue false

Sporadic Nerve Root Hemangioblastoma: A Rare Neoplasm. Treatment Strategies

Published online by Cambridge University Press:  20 October 2021

Donatella Tampieri*
Affiliation:
Department of Radiology, Kingston Health Sciences Centre Queen’s University, Kingston, Canada
John Rossiter
Affiliation:
Department of Pathology, Kingston Health Sciences Centre Queen’s University, Kingston, Canada
Alexander Menard
Affiliation:
Department of Radiology, Kingston Health Sciences Centre Queen’s University, Kingston, Canada
Ryan Alkins
Affiliation:
Department of Surgery, Division of Neurosurgery, Kingston Health Sciences Centre Queen’s University, Kingston, Canada
*
Corresponding author: Donatella Tampieri, Department of Radiology, Kingston Health Sciences Centre Queen’s University, Kingston, Canada. Email: Donatella.Tampieri@queensu.ca
Rights & Permissions [Opens in a new window]

Abstract

Information

Type
Practice Pearls
Copyright
© The Author(s), 2021. Published by Cambridge University Press on behalf of Canadian Neurological Sciences Federation
Figure 0

Figure 1: (A) Contrast-enhanced CT demonstrating a lesion in the left neural foramen at the C2–C3 level; (B) the tumor has a heterogeneous signal in T2 and (C–D) avidly enhances following Gadolinium injection and is responsible for significant compression of the spinal cord.

Figure 1

Figure 2: (A) Angiogram of the left vertebral artery demonstrating the hypervascular mass. During the TBO (B), the V4 segment of the left vertebral and left PICA are revascularized in a retrograde fashion. (C–D) Status following left vertebral occlusion using trapping technique with coils.

Figure 2

Figure 3: (A–D): Photomicrographs of hemangioblastoma at low and medium power (A, B, HPS stain) showing stromal cells with finely vacuolated cytoplasm, within a dense capillary network that is highlighted by CD31 immunolabeling (C). The stromal cells are strongly immunoreactive for inhibin alpha subunit (D). Scale bar = 500 μm for A, 60 μm for B–D.

Figure 3

Figure 4: (A–C): Postoperative MRI and CT confirming the total resection of the tumor, the resolved compression on the cord and the surgical instrumentation.